Replimune Group Analyst Price Targets

Replimune Group Inc

REPLNASDAQ

$15.58

0.956.49%

al cierre: Aug 18, 5:00 PM EST

$15.54

-0.04-0.26%

After hour: 7:22 PM EST

Ganancias: Los beneficios de Q1 2027 se publicaron el vie ago 14th, antes de la apertura del mercado

Wall Street analyst price targets and consensus rating for Replimune Group (REPL).

Price Target Range — 11 Quarters

Analyst Consensus — 9 Analysts

6Buy

2Hold

1Sell

Consensus RatingOutperform# Analysts9Avg. Consensus PT$13Upside to Avg. PT-17.1%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	JP Morgan	Anupam Rama	PT Raise	Overweight	$17→$20
Aug 7, 2026	Wedbush	Robert Driscoll	Upgrade	Neutral→Outperform	$12→$19
Aug 4, 2026	Leerink Partners	Jonathan Chang	Upgrade	Market Perform→Outperform	$11→$17
Jul 31, 2026	Cantor Fitzgerald	Li Watsek	Upgrade	Neutral→Overweight	—
Jul 31, 2026	Wedbush	Robert Driscoll	PT Raise	Neutral	$9→$12
Jun 30, 2026	Wedbush	Robert Driscoll	PT Raise	Neutral	$6→$9
Jun 1, 2026	Wedbush	Robert Driscoll	PT Raise	Neutral	$2→$6
Apr 13, 2026	Cantor Fitzgerald	Li Watsek	Downgrade	Overweight→Neutral	—
Apr 13, 2026	Leerink Partners	Jonathan Chang	Downgrade	Outperform→Market Perform	$11→$2
Apr 13, 2026	JP Morgan	Anupam Rama	Downgrade	Neutral→Underweight	—
Apr 13, 2026	Wedbush	Robert Driscoll	Downgrade	Outperform→Neutral	$19→$2
Apr 13, 2026	Jefferies	Roger Song	Downgrade	Buy→Hold	$13→$2
Apr 13, 2026	HC Wainwright & Co.	Robert Burns	Downgrade	Buy→Sell	—
Feb 5, 2026	Piper Sandler	Allison Bratzel	PT Raise	Overweight	$13→$14
Feb 4, 2026	Wedbush	Robert Driscoll	PT Raise	Outperform	$18→$19
Nov 3, 2025	BMO Capital	Evan David Seigerman	Upgrade	Underperform→Market Perform	$2→$11
Oct 27, 2025	HC Wainwright & Co.	Robert Burns	Upgrade	Neutral→Buy	$12
Oct 20, 2025	JP Morgan	Anupam Rama	Upgrade	Underweight→Neutral	$11
Oct 20, 2025	Leerink Partners	Jonathan Chang	Upgrade	Market Perform→Outperform	$3→$13
Oct 20, 2025	Wedbush	Robert Driscoll	Upgrade	Neutral→Outperform	$4→$18